Modulating sustained drug release from nanocellulose hydrogel by adjusting the inner geometry of implantable capsules

被引:37
作者
Auvinen, Vili-Veli [1 ,2 ]
Virtanen, Juhani [3 ]
Merivaara, Arto [2 ]
Virtanen, Valtteri [3 ]
Lauren, Patrick [2 ]
Tuukkanen, Sampo [3 ]
Laaksonen, Timo [1 ]
机构
[1] Tampere Univ, Fac Engn & Nat Sci, POB 541, Tampere 33014, Finland
[2] Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci, POB 56, FI-00014 Helsinki, Finland
[3] Tampere Univ, Fac Med & Hlth Technol, POB 692, Tampere 33101, Finland
关键词
3D printing; Nanocellulose; Hydrogel; Sustained drug release; DOSAGE FORMS; CELLULOSE; COMBINATION; OXIDATION;
D O I
10.1016/j.jddst.2020.101625
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanocellulose hydrogel has been shown to be an excellent platform for drug delivery and it has been lately studied as an injectable drug carrier. 3D printing is an effective method for fast prototyping of pharmaceutical devices with unique shape and cavities enabling new types of controlled release. In this study, we combined the versatility of 3D printing capsules with controlled geometry and the drug release properties of nanocellulose hydrogel to accurately modulate its drug release properties. We first manufactured non-active capsules via 3D printing from biocompatible poly(lactic acid) (PLA) that limit the direction of drug diffusion. As a novel method, the capsules were filled with a drug dispersion composed of model compounds and anionic cellulose nanofiber (CNF) hydrogel. The main benefit of this device is that the release of any CNF-compatible drug can be modulated simply by modulating the inner geometry of the PLA capsule. In the study we optimized the size and shape of the capsules inner cavity and performed drug release tests with common beta blockers metoprolol and nadolol as the model compounds. The results demonstrate that the sustained release profiles provided by the CNF matrix can be accurately modulated via adjusting the geometry of the 3D printed PLA capsule, resulting in adjustable sustained release for the model compounds.
引用
收藏
页数:6
相关论文
共 37 条
[1]   Emergence of 3D Printed Dosage Forms: Opportunities and Challenges [J].
Alhnan, Mohamed A. ;
Okwuosa, Tochukwu C. ;
Sadia, Muzna ;
Wan, Ka-Wai ;
Ahmed, Waqar ;
Arafat, Basel .
PHARMACEUTICAL RESEARCH, 2016, 33 (08) :1817-1832
[2]   Modifying release characteristics from 3D printed drug-eluting products [J].
Boetker, Johan ;
Water, Jorrit Jeroen ;
Aho, Johanna ;
Arnfast, Laerke ;
Bohr, Adam ;
Rantanen, Jukka .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 90 :47-52
[3]   Pretreatment-dependent surface chemistry of wood nanocellulose for pH-sensitive hydrogels [J].
Chinga-Carrasco, Gary ;
Syverud, Kristin .
JOURNAL OF BIOMATERIALS APPLICATIONS, 2014, 29 (03) :423-432
[4]  
Farah S., 2019, NAT MAT, V1
[5]  
Gaylo C. M., 2006, U.S. Patent No. US, Patent No. [7,027,887, 7027887]
[6]   Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing [J].
Genina, Natalja ;
Boetker, Johan Peter ;
Colombo, Stefano ;
Harmankaya, Necati ;
Rantanen, Jukka ;
Bohr, Adam .
JOURNAL OF CONTROLLED RELEASE, 2017, 268 :40-48
[7]   Effect of geometry on drug release from 3D printed tablets [J].
Goyanes, Alvaro ;
Martinez, Pamela Robles ;
Buanz, Asma ;
Basit, Abdul W. ;
Gaisford, Simon .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 494 (02) :657-663
[8]   Hydrogels: from controlled release to pH-responsive drug delivery [J].
Gupta, P ;
Vermani, K ;
Garg, S .
DRUG DISCOVERY TODAY, 2002, 7 (10) :569-579
[9]   New developments in managing opioid addiction: impact of a subdermal buprenorphine implant [J].
Itzoe, MariaLisa ;
Guarnieri, Michael .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 :1429-1437
[10]   3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles [J].
Khaled, Shaban A. ;
Burley, Jonathan C. ;
Alexander, Morgan R. ;
Yang, Jing ;
Roberts, Clive J. .
JOURNAL OF CONTROLLED RELEASE, 2015, 217 :308-314